Beta-arrestin-based Bret2 screening assay for the "non"-beta-arrestin binding CB1 receptor
{{output}}
CB1 receptor (CB1R) antagonists have been demonstrated to be effective in treating obesity and related disorders. This study has been focused on establishing a beta-arrestin 2-based screening assay for the CB1R using BRET2 technology. When the existing BRET2 s... ...
